Reviewer-Style Questions for Deviation Reports
Before a deviation report leaves your desk, run it past the questions a quality reviewer or inspector will ask. This checklist turns self-review into a defensibility test.
DSRV Intelligence
AI Pharmaceutical Quality Intelligence
Regulatory Snapshot
- Risk
- Deviation reports that leave reviewer questions unanswered — unbounded scope, evidence-free assertions, undefined effectiveness checks — surface those same gaps under inspection pressure instead.
- Case reference
- Deviation and investigation documentation expectations under 21 CFR §211.192 and quality system review practice per ICH Q10.
- Primary regulation
- 21 CFR §211.192
- Tags
- 21 CFR §211.192Deviation InvestigationsICH Q10OOSDocumentation Quality
- Inspection exposure
- ModerateDocumentation-quality gaps typically become findings when they compound across records; disciplined pre-review keeps individual reports from turning into systemic observations.
- Affected systems
- Deviation ManagementQuality ReviewDocumentation
- DSRV take
- Every "no" on a reviewer-style pre-flight check is a question you will eventually have to answer — better now, with the team and evidence at hand, than during an inspection.
- Source
- View source
Self-review with the reviewer's questions
The fastest way to strengthen a deviation report is to interrogate it the way an experienced reviewer will. The questions below are not a substitute for your quality system's review — they are a pre-flight check that surfaces the obvious gaps before formal review or inspection does.
On the problem statement
- Is the event described in factual, specific terms — what, where, when, and how much?
- Is the quality and patient-safety impact stated, or merely implied?
- Is the affected scope (batches, lots, equipment, time window) explicitly bounded?
On the investigation
- Does the report list the plausible causes considered, or jump straight to one conclusion?
- For each alternative, is there evidence that supports or rules it out?
- If the cause is "human error," does the report examine the system condition behind it?
- Is the root-cause methodology named and applied consistently?
On evidence and data
- Is every key assertion backed by a record, result, or reference I can locate?
- For an OOS, was a phased laboratory investigation performed before any conclusion on product impact?
- If a result was invalidated, is there an assignable, evidence-supported laboratory cause?
On impact, scope, and disposition
- Is the material disposition justified by the investigation's findings?
- Were other batches, lines, or products assessed for the same failure mode?
- Is any extension of scope (or the decision not to extend) explained?
On corrective and preventive action
- Does each action map to the identified cause, not to a symptom?
- Is there a preventive element where the cause could recur elsewhere?
- Is an effectiveness check defined, with a metric and a review date?
On the record itself
- Is the timeline complete and consistent, with any extensions justified?
- Are linked deviations, complaints, and change controls cross-referenced?
- Would the narrative make sense to someone reading it cold, a year from now?
Using the checklist well
Treat any "no" as a reviewer question you will eventually have to answer — better to answer it now, with the team and evidence in front of you, than under inspection pressure. The goal is not a longer report; it is a report whose reasoning a reviewer can follow and trust.
How DSRV helps
DSRV can run a deviation draft against reviewer-style questions like these and surface where the reasoning, evidence, or scope is thin — as prompts for the author, not as conclusions. The quality unit decides what to change and owns the final record.
DSRV provides decision-support intelligence for pharmaceutical quality teams. It is not a substitute for medical, legal, or regulatory advice, and its output is intended to be reviewed and owned by qualified human reviewers before any regulated decision is made.
Address this risk
To turn self-review into a defensibility test, a quality team typically needs:
- Reviewer Question ChecklistChecklistLibrary · Member
- Deviation report self-review worksheetWorksheet
Solution Library · Early access
Locked exercises are part of the DSRV Solution Library — a member library of inspection-ready checklists, matrices, and worksheets. Join the early-access list and be first in when it opens.
No spam. You'll also get the weekly brief — unsubscribe any time.
Dealing with a related issue?
If this article hits close to home, DSRV can help you assess the situation and frame a response strategy — confidentially, within 48 hours.
DSRV Intelligence
AI Pharmaceutical Quality Intelligence · DSRV Founder
Thedson is a pharmaceutical stability and quality professional with deep expertise in regulatory science, ICH guidelines, and pharmaceutical quality systems. He founded DSRV to make high-quality regulatory intelligence accessible to professionals at every career stage.
Get expert pharmaceutical intelligence in your inbox
Weekly regulatory round-ups, quality science deep-dives, and early access to the DSRV Community Forum and AI Q&A.
Subscribe FreeFree forever. No spam. Unsubscribe anytime.